1. Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing
- Author
-
Bing He, Shuning Liu, Mengxin Xu, Yunqi Hu, Kexin Lv, Yuanyuan Wang, Yong Ma, Yanmei Zhai, Xinyu Yue, Lin Liu, Hongjie Lu, Siwei Zhou, Pengbin Li, Guoqin Mai, Xiaoping Huang, Chenhang Li, Shifeng Chen, Shupei Ye, Pingsen Zhao, Yuedong Yang, Xinhua Li, Yusheng Jie, Mang Shi, Jingyi Yang, Yuelong Shu, and Yao-Qing Chen
- Subjects
COVID-19 Vaccines ,SARS-CoV-2 ,Epidemiology ,Vaccination ,Immunology ,COVID-19 ,Receptors, Antigen, B-Cell ,Viral Vaccines ,General Medicine ,Antibodies, Viral ,Microbiology ,Infectious Diseases ,Virology ,Spike Glycoprotein, Coronavirus ,Drug Discovery ,Humans ,Parasitology - Abstract
Dynamic changes of the paired heavy and light chain B cell receptor (BCR) repertoire provide an essential insight into understanding the humoral immune response post-SARS-CoV-2 infection and vaccination. However, differences between the endogenous paired BCR repertoire kinetics in SARS-CoV-2 infection and previously recovered/naïve subjects treated with the inactivated vaccine remain largely unknown. We performed single-cell V(D)J sequencing of B cells from six healthy donors with three shots of inactivated SARS-CoV-2 vaccine (BBIBP-CorV), five people who received the BBIBP-CorV vaccine after having recovered from COVID-19, five unvaccinated COVID-19 recovered patients and then integrated with public data of B cells from four SARS-CoV-2-infected subjects. We discovered that BCR variable (V) genes were more prominently used in the SARS-CoV-2 exposed groups (both in the group with active infection and in the group that had recovered) than in the vaccinated groups. The VH gene that expanded the most after SARS-CoV-2 infection was IGHV3-33, while IGHV3-23 in the vaccinated groups. SARS-CoV-2-infected group enhanced more BCR clonal expansion and somatic hypermutation than the vaccinated healthy group. A small proportion of public clonotypes were shared between the SARS-CoV-2 infected, vaccinated healthy, and recovered groups. Moreover, several public antibodies had been identified against SARS-CoV-2 spike protein. We comprehensively characterize the paired heavy and light chain BCR repertoire from SARS-CoV-2 infection to vaccination, providing further guidance for the development of the next-generation precision vaccine.
- Published
- 2022